调查哈尔滨地区接受重组人生长激素(rhGH)治疗的矮小儿童219例，探讨其病因分布情况。

采用统一的调查表，对219例矮小儿童，男性患儿147例(67. 1%)，女性72例(32.9%)，通过查阅病案，获取病史、体格检查及相关实验室检查资料，分析病因学分布情况。

本组219例应用rhGH的矮小儿童中，因生长激素缺乏(growth hormone deficiency，GHD)应用的为133例(60. 8%)，特发性矮小为60例(27.4%)，Turner综合征为15例(6.9%)，其余为宫内发育迟缓、性早熟、多种垂体激素缺乏症、软骨发育不全、甲状腺功能减低症患儿。

哈尔滨地区应用rhGH的矮小儿童，均为疗效确定的适应证患者。其中，以GHD最为多见，特发性矮小者居第2位，Turner综合征为第3位，其他原因应用rhGH的矮小儿童构成比比较，差异无显著意义。

219 children with short stature applying rhGH in harbin were investigated, etiologic distribution was explored.

219 children with short stature applying rhGH were collected by unified investigation table,among them 147 were males(67. 1%), 72 were female (32. 9%), Distribution of disease cause is analyzed through all of the children collected detail medical history and taken both physical and laboratory examination.

Children with short stature applying rhGH, 133cases (60. 8%) were diagnosed as growth hormone deficiency (GHD), 60 cases (27. 4%) were diagnosed as idiopathic short stature, 15 cases (6. 9%) were diagnosed as Turner syndrome; The rest of the short statures were attribute for the other reasons.

Children with short stature applying rhGH in Harbin were indication,GHD is a common disease among them, the second is idiopathic short stature, the third is Turner syndrome, the constituent ratio of other reasons of children with short stature applying rhGH was no significant difference.